J.A. Rammeloo
Impact in
-
- Lymphatic System and Diseases
-
- Childhood Cancer Survivors' Quality of Life
Papers in
-
- Childhood Cancer Survivors' Quality of Life 5
-
- Acute Lymphoblastic Leukemia research 6
- Co-authors
- R. A. Geerdink (1 shared paper)Frederic A. M. Hennekam (1 shared paper)Raoul C. M. Hennekam (1 shared paper)Ben C.J. Hamel (1 shared paper)P Kraus (1 shared paper)Elisabeth R. van Wering (6 shared papers)A van der Does-van den Berg (4 shared papers)Stefan Suciu (4 shared papers)
- Journals
- European Journal of Cancer (1 paper)European Journal of Endocrinology (1 paper)Leukemia Research (1 paper)American Journal of Medical Genetics (1 paper)PubMed (2 papers)
- Partner nations
- NetherlandsBelgium
In The Last Decade
J.A. Rammeloo
9 papers receiving 190 citations
Peers
Comparison fields: 5 of 41
- Oncology 61
- Pediatrics, Perinatology and Child Health 36
- Surgery 78
- Public Health, Environmental and Occupational Health 42
- Hematology 17
Countries citing papers authored by J.A. Rammeloo
This map shows the geographic impact of J.A. Rammeloo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.A. Rammeloo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.A. Rammeloo more than expected).
Fields of papers citing papers by J.A. Rammeloo
This network shows the impact of papers produced by J.A. Rammeloo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.A. Rammeloo. The network helps show where J.A. Rammeloo may publish in the future.
Co-authors
The 20 scholars most cited alongside J.A. Rammeloo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1989 | 118 | |
| 2 | Effectiveness of rubidomycin in induction therapy with vincristine, prednisone, and L-asparaginase for standard risk childhood acute lymphocytic leukemia: results of a Dutch phase III study (ALL V). A report on behalf of the Dutch Childhood Leukemia Study Group (DCLSG). | 1989 | 20 |
| 3 | 1996 | 18 | |
| 4 | 1991 | 17 | |
| 5 | 1991 | 11 | |
| 6 | 1987 | 5 | |
| 7 | Gyrodontaceae p.p. (Boletineae) | 1983 | 5 |
| 8 | [Results of treatment of children with acute lymphatic leukemia (ALL) according to the ALL V protocol of the Netherlands Working Group on Leukemia in Children]. | 1988 | 1 |
| 9 | 1986 | 1 |
About J.A. Rammeloo
J.A. Rammeloo is a scholar working on Pediatrics, Perinatology and Child Health, Public Health, Environmental and Occupational Health, Pathology and Forensic Medicine, Surgery and Molecular Biology, having authored 9 papers that have together received 196 indexed citations. Recurring topics across this work include Acute Lymphoblastic Leukemia research (6 papers), Childhood Cancer Survivors' Quality of Life (5 papers), Lymphoma Diagnosis and Treatment (2 papers), Acute Myeloid Leukemia Research (1 paper), Genetic and rare skin diseases. (1 paper), Lymphatic Disorders and Treatments (1 paper), Botany, Ecology, and Taxonomy Studies (1 paper) and Vascular Malformations and Hemangiomas (1 paper). The work is most often cited by research in Oncology (61 citations), Pediatrics, Perinatology and Child Health (36 citations), Surgery (78 citations), Public Health, Environmental and Occupational Health (42 citations) and Hematology (17 citations). J.A. Rammeloo has collaborated with scholars based in Netherlands and Belgium. Frequent co-authors include R. A. Geerdink, Frederic A. M. Hennekam, Raoul C. M. Hennekam, Ben C.J. Hamel, P Kraus, Elisabeth R. van Wering, A van der Does-van den Berg, Stefan Suciu, Willem A. Kamps and G E van Zanen. Their work appears in journals such as European Journal of Cancer, European Journal of Endocrinology, Leukemia Research, American Journal of Medical Genetics and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.